Some mechanisms that lead tumor cells to escape immunotherapy are the downregulation or mutating molecules involved in the IFN-γ signalling pathway by tumor cells, like the loss-of-function of genes encoding for JAK1/2 and changes in STAT1 to escape the influence of IFN-γ [86,87]. The gene discussed is IFNG; the disease is neoplasm.